Board Meeting Scheduled to Consider Q2 and H1 FY2027 Financial Results
P&G Health's board will meet on November 2, 2026, to review and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
- Board Meeting Date
- November 2, 2026
- Financial Results Period
- Quarter and half-year ended September 30, 2026
- Results Status
- Unaudited financial results
Board Meeting Schedule
The company's board will meet on November 2, 2026, to approve unaudited financial results for two reporting periods: the quarter ended September 30, 2026 (Q2 FY2027) and the half-year ended the same date (H1 FY2027).
What This Means
- This is a standard board meeting to review and sign off on quarterly and half-yearly results before they are disclosed to investors and the stock exchanges.
- The results will be unaudited at this stage; audited full-year results typically come later.
- The disclosure itself is a regulatory requirement under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, and does not convey any material news about the company's performance.
- Investors will see the actual financial figures—revenue, profit, margins and other metrics—when the results are published, which usually happens shortly after the board meeting.
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.